Open Access Open Access  Restricted Access Subscription Access

Pipeline for Novel Product Isolation from Marine sponges (Phylum: Porifera) and Informatics Tools for the Process

Sheeja M S


Pharmaceutical industries are still searching for innovative drugs. Several diseases diagnosed hitherto have no effective medicine. Scientists are trying to discover novel drug entities with low toxicity to cure and prevent such diseases. A lead compound that has the properties of desired new drug is generally used as a model for chemical modification. Bacteria, fungi, plants and marine organisms consist of several natural products with low molecular mass and they exhibit unique structural diversity, and are used for identifying new lead structures. Marine sponges act as reservoirs of bioactive compounds with wide spectrum application in nutraceutical and pharmaceutical industries. Bioactive compounds such as alkaloids, terpenoids, sterols, peptides, polyketides etc. have been isolated from these organisms. There are different microbial communities (bacteria, fungi, actinomycetes) with novel bioactive compounds, which can be isolated from sponges and identification and isolation of novel compounds from sponges is a current area of research. The paper discusses the novel compound identification pipeline from marine sponges and outlines the pertinent informatics tools for the process.


Microbiome, Bioactive compounds, Sponge barcoding, Molecular taxonomy, Marine Natural Products

Full Text:



Alcaraz, M.J. and Payá, M. 2006. Marine sponge metabolites for the control of inflammatory diseases. Current Opinion in Investigational Drugs, 7: 974-979.

Aneiros, A. and A. Garateix, 2004. Bioactive peptides from marine sources: pharmacological properties and isolation procedures. J. Chromato, 803: 41-53.

Bell, J.J. 2008. The functional roles of marine sponges. Estuar. Coast. Shelf Sci., 79: 341-353.

Blunt, J.W., Copp, B.R., Munro, M.H.G., Northcote, P.T. and Prinsep, M.R. 2004. Marine natural products. Mar. Nat.Prod., 21: 1-49.

Brusca, R.C. and Brusca, G.J. 1990. Phylum Porifera: The sponges. In: Invertebrates (Sinauer, A.D., ed.), Sinauer Press, Sunderland, Mass, 181-120.

Edrada, R.A., Heubes, M., Brauers, G., Wray, V., Berg, A., Grafe, U., Wohlfarth, M., Muhlbacher, J., Schaumann, K., Sudarsono, S., Bringmann, G. and Proksch, P. 2002. Online analysis of xestodecalactones A-C, novel bioactive metabolites from the fungus Penicillium cf. montanense and their subsequent isolation from the sponge Xestospongia exigua. J. Nat. Prod., 65(11): 1598-604.

Erpenbeck, D., Breeuwer, J.A.J., van der Velde, H.C. and van Soest, R.W.M. 2002. Unravelling host and symbiont phylogenies of halichondrid sponges (Demospongiae, Porifera) using a mitochondrial marker. Mar. Biol., 141: 377-386.

Faulkner, D.J. 2002. Marine natural products. Nat. Prod. Rep., 19: 1-48.

Folmer, O., Black, M., Hoeh, W., Luts, R. and Vrijenhoek, R. 1994. DNA primer for amplification of mitochondrial cytochrome C oxidase subunit I from diverse metazoan invertebrates. Mol. Mar. Biol. Biotechnol., 3: 294-299.

Gordaliza, M. 2010. Cytotoxic terpene quinones from marine sponges. Mar. Drugs, 8: 2849-2870.

Guleria, S., Walia, A., Chauhan, A. and Shirkot, C.K. 2016. Purification and characterization of detergent stable alkaline protease from Bacillus amyloliquefaciens SP1 isolated from apple rhizosphere. J. Basic Microbiol., 56:138–152.

Hall, K.A. & Hooper, J.N.A. 2019. SpongeMaps - an online community for sponge taxonomy.

Jha, R.K. and Zi-rong, X. 2004. Biomedical compounds from marine organisms. Mar. Drugs, 2: 123–146.

Kamalakkannan, P. 2015. Marine Sponges a Good Source of Bioactive Compounds in Anticancer Agents. Int. J. Pharm. Sci. Rev. Res., 31: 132-135.

Kulawik, P., Özogul, F., Glew, R. and Özogul, Y. 2013. Significance of antioxidants for seafood safety and human health. J. Agri. Food Chem., 61: 475-491.

Lavrov, D., Pett, W. and Voigt, O., et al 2013. Mitochondrial DNA of Clathrina clathrus (Calcarea, Calcinea): six linear chromosomes, fragmented rRNAs, tRNA editing, and a novel genetic code. Mol. Biol. Evol., 30: 865–880.

Lordan, S., Ross, R.P. and Stanton, C. 2011. Marine bioactives as functional food ingredients: potential to reduce the incidence of chronic diseases. Mar. Drugs, 9: 1056–1100.

Lyu, C., et al. Nucleic Acids Res., 2021, 49(D1): D509-D515. doi: 10.1093/nar/gkaa763

Moitinho-Silva, L., Nielsen, S., Amir, A., Gonzalez, A., Ackermann, G.L. et al. 2017. The sponge microbiome project. GigaScience, 6: 1–7.

Molinski, T.F., Dalisay, D.S., Lievens, S.L. and Sludes, J.P. 2009. Drug development from marine natural products. Nat. Rev. Drug Discovery, 8: 69-85.

Müller, W.E.G., Batel, R., Schroder, H.C. and Muller, I.M. 2004. Traditional and modern biomedical prospecting: Part I-the history: Sustainable exploitation of biodiversity (sponges and invertebrates) in the Adriatic Sea in Rovinj (Croatia). Evidence-Based Complement. Altern. Med., 1: 71-82.

Nichols, S.A. 2005. An evaluation of support for order-level monophyly and interrelationships within the class Demospongiae using partial data from the large subunit rDNA and cytochrome oxidase subunit I. Mol. Phylogen. Evol., 34: 81–96.

Petersen, L.E., Kellermann, M.Y. and Schupp, P.J. 2019. Secondary metabolites of marine microbes: From natural products chemistry to chemical ecology. In: YOUMARES 9—The Oceans: Our Research, Our Future (Jungblut, S., Liebich, V., Bode-Dalby, M., eds.), Springer: Berlin/Heidelberg, Germany, 159–180.

Ruocco, N., Esposito, R., Zagami, G., Bertolino, M., De Matteo, S., Sonnessa, M., Andreani, F., Crispi, S., Zupo, V., & Costantini, M. 2021. Microbial diversity in Mediterranean sponges as revealed by metataxonomic analysis. Scientific reports, 11(1), 21151.

Schmitt, S., Tsai, P., Bell, J., Fromont, J., Ilan, M., Lindquist, N., Perez, T., Rodrigo, A., Schupp, P.J., Vacelet, J., Webster, N., Hentschel, U. and Taylor, M.W. 2012. Assessing the complex sponge microbiota: core, variable and species-specific bacterial communities in marine sponges. ISME J, 6(3):564-76.

Simmons, T.L., Andrianasolo, E., McPhail, K., Flatt, P. and Gerwick, W.H. 2005. Marine natural products as anticancer drugs. Molecular Cancer Therapeutics, 4: 333-342.

Tramper, J. 1999. Cultivation of Marine Sponges. Detmer Sipkema. Process Engineering Group, Wageningen University, The Netherlands, 184pp.

Vargas, S., Schuster, A., Sacher, K., Büttner, G., Schätzle, S., Läuchli, B., Hall, K., Hooper, J. N., Erpenbeck, D., & Wörheide, G. 2012. Barcoding sponges: an overview based on comprehensive sampling. PloS one, 7(7), e39345.

Varijakzhan, D., Loh, J.Y., Yap, W.S., Yusoff, K., Seboussi, R., Lim, S.H.E., Lai, K.S. and Chong, C.M. 2021. Bioactive Compounds from Marine Sponges: Fundamentals and Applications. Mar. Drugs, 19: 246.


  • There are currently no refbacks.

Informatics Studies Print Version:  ISSN: 2320-530X (Print)